No Data
Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Corvus Pharma Analyst Ratings
Ladenburg Thalmann Maintains Corvus Pharmaceuticals(CRVS.US) With Buy Rating, Raises Target Price to $21
Corvus Stock Up on Initiation of Phase III Lymphoma Study on Lead Drug
Corvus Spikes as Late-stage Trial for Lead Asset Announced
Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial Of Soquelitinib For Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma